64. Thrombotic thrombocytopenic purpura Clinical trials / Disease details
Clinical trials : 92 / Drugs : 85 - (DrugBank : 21) / Drug target genes : 18 - Drug target pathways : 76
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT05568147 (ClinicalTrials.gov) | October 1, 2022 | 25/9/2022 | Aspirin for Prophylaxis of TTP | A Prospective Multicenter Clinical Study of Aspirin for Prophylaxis in Patients With Hereditary or Acquired Thrombotic Thrombocytopenic Purpura | Thrombotic Thrombocytopenic Purpura | Drug: Aspirin tablet;Drug: Placebo | The First Affiliated Hospital of Soochow University | NULL | Not yet recruiting | N/A | N/A | All | 100 | Phase 2/Phase 3 | NULL |